Literature DB >> 21543968

Laparoscopic anterior versus posterior fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials.

Joris A Broeders1, David J Roks, Usama Ahmed Ali, Werner A Draaisma, André J Smout, Eric J Hazebroek.   

Abstract

OBJECTIVE: To compare short- and long-term outcome after laparoscopic anterior fundoplication (LAF) versus posterior fundoplication (LPF) through a systematic review and meta-analysis of randomized clinical trials (RCTs). SUMMARY OF BACKGROUND DATA: LPF is currently considered the surgical therapy of choice for gastroesophageal reflux disease (GERD). Alternatively, LAF has been alleged to reduce troublesome dysphagia and gas-related symptoms.
METHODS: Four electronic databases (MEDLINE, EMBASE, Cochrane Library, and ISI web of Knowledge CPCI-S) were searched for RCTs comparing primary LAF versus LPF for GERD. The methodological quality was evaluated to assess bias risk. Primary outcomes were esophageal acid exposure time, heartburn, Dakkak dysphagia score (0-45) and reoperation rate. Short- and long-term results were pooled separately in meta-analyses as risk ratios (RRs) and weighted mean differences (WMDs).
RESULTS: Eleven reports on 7 eligible RCTs (anterior vs. posterior total [n = 5]; anterior vs. posterior partial [n = 2]) comparing LAF (n = 345) versus LPF (n = 338) were identified. Short-term (6-12 months) esophageal acid exposure time (3.3% vs. 0.8%: WMD 2.04; 95% confidence interval [CI] [0.84-3.24]; P < 0.001), heartburn (21% vs. 8%; RR 2.71; 95%CI [1.72-4.26]; P < 0.001) and reoperation rate (8% vs. 4%; RR 1.94; 95%CI [0.97-3.87]; P = 0.06) were higher after LAF. In contrast, the Dakkak dysphagia score was lower after LAF (2.5 vs. 5.7; WMD -2.87; 95%CI [-3.88 to -1.87]; P < 0.001). There were no short-term differences in prevalence of esophagitis, regurgitation and perioperative outcomes. The higher rate of heartburn after LAF persisted during long-term (2-10 years) follow-up (31% vs. 14%; RR 2.15; 95% CI [1.49-3.09]; P < 0.001) with more PPI use (25% vs. 10%; RR 2.53; 95% CI [1.40-4.45]; P = 0.002). The long-term reoperation rate was twice as high after LAF (10% vs. 5%; RR 2.12; 95% CI [1.07-4.21]; P = 0.03). Long-term Dakkak dysphagia scores, inability to belch, gas bloating and satisfaction were not different.
CONCLUSIONS: Esophageal acid exposure time and the prevalence of heartburn are higher after LAF compared with LPF. In the short-term this is counterbalanced by less severe dysphagia. However, dysphagia scores become similar in the long-term, with a persistent substantial increase in prevalence of heartburn and PPI use after LAF. The reoperation rate is twice as high after LAF as well, mainly due to reinterventions for recurrent GERD. The prevalence of gas-related symptoms is similar. These results lend level 1a support for the use of LPF as the surgical treatment of choice for GERD.

Entities:  

Mesh:

Year:  2011        PMID: 21543968     DOI: 10.1097/SLA.0b013e31821d4ba0

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Laparoscopic surgery: A qualified systematic review.

Authors:  Alexander Buia; Florian Stockhausen; Ernst Hanisch
Journal:  World J Methodol       Date:  2015-12-26

2.  [Laparoscopic anterior versus posterior fundoplication : new evidence level from meta-analysis].

Authors:  B H A von Rahden; C-T Germer
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

3.  What is the best anti-reflux operation? All fundoplications are not created equal.

Authors:  Sarah K Thompson; David I Watson
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

Review 4.  New insights in gastroesophageal reflux, esophageal function and gastric emptying in relation to dysphagia before and after anti-reflux surgery in children.

Authors:  M J Smits; C M Loots; M A Benninga; T I Omari; M P van Wijk
Journal:  Curr Gastroenterol Rep       Date:  2013-10

5.  Comparison of Laparoscopic 270° Posterior Partial Fundoplication vs Total Fundoplication for the Treatment of Gastroesophageal Reflux Disease: A Randomized Clinical Trial.

Authors:  Bengt S Håkanson; Lars Lundell; Ami Bylund; Anders Thorell
Journal:  JAMA Surg       Date:  2019-06-01       Impact factor: 14.766

6.  Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.

Authors:  John Maret-Ouda; Karl Wahlin; Miia Artama; Nele Brusselaers; Martti Färkkilä; Elsebeth Lynge; Fredrik Mattsson; Eero Pukkala; Pål Romundstad; Laufey Tryggvadóttir; My von Euler-Chelpin; Jesper Lagergren
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

7.  Is that 'floppy' fundoplication tight enough?

Authors:  Brexton Turner; Melissa Helm; Emily Hetzel; Jon C Gould
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

8.  Backflow prevention mechanism of laparoscopic Toupet fundoplication using high-resolution manometry.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Se Ryung Yamamoto; Shunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Surg Endosc       Date:  2015-09-30       Impact factor: 4.584

Review 9.  Surgical treatment of gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2012-04-12       Impact factor: 3.445

10.  More beads, more peristaltic reserve, better outcomes: factors predicting postoperative dysphagia after magnetic sphincter augmentation.

Authors:  Rebeca Dominguez-Profeta; Joslin N Cheverie; Rachel R Blitzer; Arielle M Lee; Lauren McClain; Ryan C Broderick; Bryan J Sandler; Garth R Jacobsen; Santiago Horgan; David C Kunkel
Journal:  Surg Endosc       Date:  2020-10-30       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.